Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis

INTRODUCTION: Indirect treatment comparison was used to compare approved doses of baricitinib and dupilumab for treating adult patients with moderate-to-severe atopic dermatitis (AD) who are candidates for systemic therapy. METHODS: Baricitinib and dupilumab were compared (Bucher method) at weeks 4...

Descripción completa

Detalles Bibliográficos
Autores principales: de Bruin-Weller, Marjolein S., Serra-Baldrich, Esther, Barbarot, Sebastien, Grond, Susanne, Schuster, Christopher, Petto, Helmut, Capron, Jean-Philippe, Raibouaa, Afaf, Werfel, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209542/
https://www.ncbi.nlm.nih.gov/pubmed/35543919
http://dx.doi.org/10.1007/s13555-022-00734-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209542/
https://www.ncbi.nlm.nih.gov/pubmed/35543919
http://dx.doi.org/10.1007/s13555-022-00734-w

Ejemplares similares